NCT07218575 2025-10-20
Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations
Boston Children's Hospital
Phase 2/3 Not yet recruiting
Clinical Trials
5 trialsNCT05833815 2024-08-13
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Banaras Hindu University
Phase 2/3 Recruiting
NCT02860494 2021-05-03
EVEROST
Hospices Civils de Lyon
Phase 2/3 Withdrawn
NCT03285802 2020-02-05
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Greater Baltimore Medical Center
Phase 2/3 Completed
NCT01730209 2015-05-05
RAPIT
Erasmus Medical Center
Phase 2/3 Unknown